Dunelm Group (LON:DNLM – Free Report) had its target price boosted by JPMorgan Chase & Co. from GBX 1,140 ($15.27) to GBX 1,170 ($15.67) in a research note issued to investors on Tuesday morning, MarketBeat reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.
A number of other brokerages have also recently issued reports on DNLM. Deutsche Bank Aktiengesellschaft reissued a hold rating and issued a GBX 1,060 ($14.19) target price on shares of Dunelm Group in a research report on Thursday, September 12th. Berenberg Bank raised their target price on shares of Dunelm Group from GBX 1,410 ($18.88) to GBX 1,470 ($19.68) and gave the stock a buy rating in a research report on Tuesday, September 17th. Finally, Canaccord Genuity Group reiterated a buy rating and issued a GBX 1,325 ($17.74) price target on shares of Dunelm Group in a research report on Tuesday, September 17th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Dunelm Group currently has a consensus rating of Hold and an average target price of GBX 1,220.83 ($16.35).
Get Our Latest Research Report on DNLM
Dunelm Group Stock Performance
Dunelm Group Cuts Dividend
The business also recently declared a dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Thursday, October 31st will be paid a dividend of GBX 27.50 ($0.37) per share. This represents a dividend yield of 2.23%. The ex-dividend date is Thursday, October 31st. Dunelm Group’s dividend payout ratio (DPR) is presently 5,945.95%.
About Dunelm Group
Dunelm Group plc retails homewares in the United Kingdom. The company offers furniture and beds products, which include bedroom, living room, dining room, and other furniture, as well as bed and mattresses, and sofas and armchairs; bedding products comprising bed linen, dorma, baby and kid's bedding, and duvets, pillows, and protectors; curtains and rugs; and venetian, roller, roman, vertical, and made to measure blinds.
Further Reading
- Five stocks we like better than Dunelm Group
- How to Start Investing in Real Estate
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Investing in Travel Stocks Benefits
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Pros And Cons Of Monthly Dividend Stocks
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Dunelm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dunelm Group and related companies with MarketBeat.com's FREE daily email newsletter.